In situ neoplasia in lymph node pathology

Naoki Oishi, Santiago Montes-Moreno, Andrew L Feldman

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


In situ neoplasia represents the earliest form of malignant progression and is characterized by localization limited to the compartment corresponding to the cell of origin. Like other cancers, lymphoid neoplasms are considered to develop by multistep pathogenetic mechanisms. However, because of the circulating nature of lymphocytes, in situ lymphoid neoplasia may be difficult to identify histopathologically, and the compartment to which it is restricted may be physiological rather than strictly anatomical. The 2016 WHO classification of lymphoid neoplasms recognizes two in situ entities: in situ follicular neoplasia (ISFN) and in situ mantle cell neoplasia (ISMCN). This review summarizes the clinical features, histopathology, genetics, and differential diagnoses of these two entities, including distinction from both their overly malignant counterparts and a variety of reactive processes.

Original languageEnglish (US)
JournalSeminars in Diagnostic Pathology
StateAccepted/In press - Jan 1 2017


  • 14)
  • 18)
  • Follicular lymphoma
  • In situ follicular neoplasia
  • In situ mantle cell neoplasia
  • Lymphomagenesis
  • Mantle cell lymphoma
  • T(11
  • T(14

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'In situ neoplasia in lymph node pathology'. Together they form a unique fingerprint.

Cite this